SG11201808322PA - Carboxylic acid for treating/preventing nasal congestion - Google Patents

Carboxylic acid for treating/preventing nasal congestion

Info

Publication number
SG11201808322PA
SG11201808322PA SG11201808322PA SG11201808322PA SG11201808322PA SG 11201808322P A SG11201808322P A SG 11201808322PA SG 11201808322P A SG11201808322P A SG 11201808322PA SG 11201808322P A SG11201808322P A SG 11201808322PA SG 11201808322P A SG11201808322P A SG 11201808322PA
Authority
SG
Singapore
Prior art keywords
carboxylic acid
international
nasal congestion
treating
acceptable salt
Prior art date
Application number
SG11201808322PA
Other languages
English (en)
Inventor
Bettina Ernst
Original Assignee
Proponent Biotech Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proponent Biotech Gmbh filed Critical Proponent Biotech Gmbh
Publication of SG11201808322PA publication Critical patent/SG11201808322PA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG11201808322PA 2016-05-17 2017-05-17 Carboxylic acid for treating/preventing nasal congestion SG11201808322PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16169882 2016-05-17
PCT/EP2017/061832 WO2017198702A1 (en) 2016-05-17 2017-05-17 Carboxylic acid for treating/preventing nasal congestion

Publications (1)

Publication Number Publication Date
SG11201808322PA true SG11201808322PA (en) 2018-10-30

Family

ID=56014856

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201808322PA SG11201808322PA (en) 2016-05-17 2017-05-17 Carboxylic acid for treating/preventing nasal congestion
SG10202006016QA SG10202006016QA (en) 2016-05-17 2017-05-17 Carboxylic acid for treating/preventing nasal congestion

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10202006016QA SG10202006016QA (en) 2016-05-17 2017-05-17 Carboxylic acid for treating/preventing nasal congestion

Country Status (13)

Country Link
US (1) US20200000751A1 (ru)
EP (1) EP3458043A1 (ru)
JP (1) JP6975473B2 (ru)
KR (1) KR102430892B1 (ru)
CN (1) CN109152754A (ru)
AU (1) AU2017266726A1 (ru)
BR (1) BR112018072177A2 (ru)
CA (1) CA3020485A1 (ru)
CL (1) CL2018003270A1 (ru)
MX (1) MX2018013475A (ru)
RU (1) RU2018143564A (ru)
SG (2) SG11201808322PA (ru)
WO (1) WO2017198702A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11948678B2 (en) * 2009-10-14 2024-04-02 Trice Imaging, Inc. Systems and devices for encrypting, converting and interacting with medical images
US11206245B2 (en) * 2009-10-14 2021-12-21 Trice Imaging, Inc. Systems and devices for encrypting, converting and interacting with medical images

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063363A (en) * 1997-05-27 2000-05-16 Goodwin; Gary J Treatment for upper respiratory tract infections with potassium salts
BR9814417A (pt) * 1997-12-23 2000-10-10 Schering Corp Composição para o tratamento de doenças respiratórias e da pele, compreendendo pelo menos um antagonista de leucotrieno e pelo menos uma anti-histamina
US8912174B2 (en) * 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
DE10337186A1 (de) * 2003-08-13 2005-03-17 Merck Patent Gmbh Wässrige Wirkstoff-Lösung
US20070256812A1 (en) * 2006-04-19 2007-11-08 Wen-Chen Wei Multidirectional heat dissipating structure
US20070286812A1 (en) * 2006-06-09 2007-12-13 Toutounghi Camille Nasal formulation
ES2748632T3 (es) * 2012-10-03 2020-03-17 Proponent Biotech Gmbh Composición farmacéutica que comprende ácido propiónico para uso en el tratamiento de infecciones víricas

Also Published As

Publication number Publication date
RU2018143564A3 (ru) 2020-07-23
MX2018013475A (es) 2019-08-12
CN109152754A (zh) 2019-01-04
EP3458043A1 (en) 2019-03-27
RU2018143564A (ru) 2020-06-17
BR112018072177A2 (pt) 2019-02-12
WO2017198702A1 (en) 2017-11-23
US20200000751A1 (en) 2020-01-02
JP6975473B2 (ja) 2021-12-01
KR20190009294A (ko) 2019-01-28
CA3020485A1 (en) 2017-11-23
KR102430892B1 (ko) 2022-08-09
SG10202006016QA (en) 2020-07-29
AU2017266726A1 (en) 2018-10-11
CL2018003270A1 (es) 2019-02-22
JP2019516797A (ja) 2019-06-20

Similar Documents

Publication Publication Date Title
SG11201908330PA (en) Farnesoid x receptor agonists and uses thereof
SG11201408174UA (en) Antibody formulation
SG11201804170RA (en) Polycyclic tlr7/8 antagonists and use thereof in the treatment of immune disorders
SG11201808990QA (en) Compositions for topical application of compounds
SG11201806863WA (en) Tetracyclic pyridone compounds as antivirals
SG11201809344QA (en) Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde
SG11201908512YA (en) Somatostatin modulators and uses thereof
SG11201407397WA (en) Formulations and methods for vaginal delivery of antiprogestins
SG11201900349VA (en) Somatostatin modulators and uses thereof
SG11201408318RA (en) Compositions and methods for transmucosal absorption
SG11201809908TA (en) Stabilized glycopeptide antibiotic formulations
SG11201906436VA (en) Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same
SG11201808237UA (en) Substituted indole compound derivatives as dengue viral replication inhibitors
SG11201811209QA (en) Oral gastroretentive formulations and uses thereof
SG11201907804QA (en) Pharmaceutical composition comprising selexipag
SG11201811580SA (en) Compositions, devices, and methods for the treatment of alcohol use disorder
SG11201809100QA (en) Use of gram negative species to treat atopic dermatitis
SG11201900558RA (en) Spiro-lactam nmda receptor modulators and uses thereof
SG11201900551WA (en) Spiro-lactam nmda receptor modulators and uses thereof
SG11201900546UA (en) Spiro-lactam and bis-spiro-lactam nmda receptor modulators and uses thereof
SG11201408240TA (en) Treatment of motor and movement disorder side effects associated with parkinson's disease treatments
SG11201804057TA (en) An actuator housing for a metered dose inhaler device
SG11201907159SA (en) Treatment of hidradenitis suppurativa
SG11201407110QA (en) Novel dosage form and formulation of abediterol
SG11201901063SA (en) Therapeutic agents for neurodegenerative diseases